Back to Search
Start Over
Valneva, Pfizer announce positive phase 2 paediatric data for Lyme disease vaccine candidate
- Source :
- PharmaBiz. April 27, 2022
- Publication Year :
- 2022
-
Abstract
- Valneva SE, a specialty vaccine company, and Pfizer Inc. reported positive phase 2 paediatric data for their Lyme disease vaccine candidate, VLA15. Based on these new results, Valneva and Pfizer [...]
- Subjects :
- Pfizer Inc. -- Product development -- Planning
Valneva SE -- Product development -- Planning
Biological products industry -- Product development -- Planning
Pediatrics
Biotechnology industry -- Product development -- Planning
Clinical trials
Vaccines -- Product development -- Planning
Lyme disease
Pharmaceutical industry -- Product development -- Planning
Company business planning
Pharmaceuticals and cosmetics industries
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.701705727